Trial intelligence / Profile preview

Diatom Shells for Aspiration Detection

NCT02301845Phase 1Withdrawn

Sponsor
Massachusetts General Hospital
Start
Feb 2016
Primary completion
Mar 2016
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of diatom shells in aspiration pneumonia, sponsored by Massachusetts General Hospital. Primary endpoint: Cuff leak and microaspiration at 3 days. Planned start Feb 2016; status: withdrawn.

02

Drugs

diatom shells
03

Conditions

aspiration pneumonia

Beyond the preview

Go deeper on NCT02301845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02301845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call